Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16900285 | 0.83 | USP2 (0.62) | USP2LMNATSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL8512156 | 0.83 | USP2 (0.49) | USP2LMNATSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL12759483 | 0.80 | SIGMAR1 (0.56) | USP2TSHRSMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL13239880 | 0.80 | SMN1; SMN2 (0.53) | USP2LMNATSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL9881207 | 0.80 | SMN1; SMN2 (0.57) | USP2LMNATSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL9881206 | 0.79 | HTR7 (0.57) | USP2LMNATSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL30266369 | 0.79 | SIGMAR1 (0.55) | USP2TSHRSMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL29406946 | 0.79 | SIGMAR1 (0.55) | USP2TSHRSMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL28334618 | 0.79 | SIGMAR1 (0.55) | USP2TSHRSMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL28216303 | 0.79 | SIGMAR1 (0.55) | USP2TSHRSMN1; SMN2ALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120133273-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-31 | — | — | US | disclosed |
| US-20120133273-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-31 | — | — | US | disclosed |
| US-20120133273-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-31 | — | — | US | disclosed |
| WO-2012070596-A1 | ORGANOMETALLIC COMPLEX, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120133273-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | LAGE3, CRY1, CYBA | USP2 3536/4885LMNA 3845/4885TSHR 3302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.